Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

NCT00857142 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: oxymorphone hydrochloride
DRUG: Opana

Sponsor

Sandoz